Managing Quality & Risk:
Virtual Compounding Quality Discussion
October 29, 2025 | 12-1:30pm (eastern)
FDA's Quality Discussion Series is tailored for outsourcing facilities interested in advancing quality and focuses on topics related to quality culture and best practices. The Foundation is collaborating with the FDA Compounding Quality Center of Excellence to convene a virtual discussion on managing quality and risk on October 29, 2025.
Speakers will include:
- Susan (Sue) Schniepp, Distinguished Fellow, Regulatory Compliance Associates
- David Short, Chief Quality Officer, QuVa Pharma
Who should attend:
- Outsourcing facilities management and staff
- Purchasers of compounded drugs
- Pharmacy organizations
Learn more about the FDA Compounding Quality Center of Excellence and the Quality Discussion Series.